(Q52424747)

1 May 2018

title

Amikacin once daily: a new dosing regimen based on drug pharmacokinetics. (English)

1 reference

1 May 2018

1 reference

1 reference

Maller R

1

1 reference

1 May 2018

Emanuelsson BM

series ordinal

2

1 reference

1 May 2018

Isaksson B

series ordinal

3

1 reference

1 May 2018

Nilsson L

series ordinal

4

1 reference

1 May 2018

publication date

1 January 1990

1 reference

1 May 2018

Scandinavian Journal of Infectious Diseases

published in

1 reference

1 May 2018

volume

22

1 reference

1 May 2018

issue

5

1 reference

1 May 2018

page(s)

575-579

1 reference

1 May 2018

Why Monitor Serum Levels of Gentamicin?

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

A study of amikacin given once versus twice daily in serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

Bioavailability--a problem in equivalence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

Clinical Pharmacokinetics of Aminoglycoside Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

Pharmacokinetics of amikacin in patients with renal insufficiency: relation of half-life and creatinine clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

Comparative pharmacokinetics of amikacin and kanamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

Modification in the pharmacokinetics of amikacin during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027099

10.3109/00365549009027099

21 January 2018

Identifiers

DOI

1 reference

1 May 2018

1 reference

1 May 2018